MiniMed Group, Inc.
MMED Healthcare Medical Instruments & Supplies
MiniMed Group, Inc.’s revenue for fiscal 2026 (year ended April 2026) was $3.1 billion, up 14.3% from fiscal 2025.
Follow MMED
Alert me
MiniMed Group, Inc. (MMED) Debt to equity
MiniMed Group, Inc.'s debt to equity at the end of the quarter to 31 July 2026 was 0.0×, down 0.0× from fiscal 2026 (0.0×). That is below the Medical Instruments & Supplies industry median of 0.1× and in line with the Healthcare sector median of 0.0×.
Debt to equity, annual
Embed this chart
Annual newest first
| Period | Debt to equity | Change |
|---|---|---|
| FY2026 | 0.0× | — |
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
Quarterly newest first
| Period | Debt to equity | Change |
|---|---|---|
| Jul 2026 | 0.0× | — |
| Apr 2026 | 0.0× | — |
| Jan 2026 | 0.0× | — |
| Jul 2025 | 0.0× | — |
| 2 more quarters | Free account |
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| PLSE Pulse Biosciences, Inc compare | 0.0× |
| MMED MiniMed Group, Inc. | 0.0× |
| ATRC AtriCure, Inc. compare | 0.1× |
| STVN Stevanato Group S.p.A. compare | 0.3× |
| MMSI Merit Medical Systems, Inc. compare | 0.4× |
| NVST Envista Holdings Corporation compare | 0.5× |
| ICUI ICU Medical, Inc. compare | 0.5× |
| BLCO Bausch + Lomb Corporation compare | 0.8× |
| TFX Teleflex Incorporated compare | 1.0× |
| Medical Instruments & Supplies industry median | 0.1× |
| Healthcare sector median | 0.0× |
| Market median | 0.1× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on MMED
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Shares outstanding
- Book value per share
- The full statement